Suppr超能文献

针对 SARS-CoV-2 刺突蛋白保守区域的单链可变抗体片段的研制。

Development of a single-chain variable antibody fragment against a conserved region of the SARS-CoV-2 spike protein.

机构信息

Department of Immunology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.

出版信息

Sci Rep. 2024 Jun 22;14(1):14419. doi: 10.1038/s41598-024-64103-7.

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has prolonged the duration of the pandemic because of the continuous emergence of new variant strains. The emergence of these mutant strains makes it difficult to detect the virus with the existing antibodies; thus, the development of novel antibodies that can target both the variants as well as the original strain is necessary. In this study, we generated a high-affinity monoclonal antibody (5G2) against the highly conserved region of the SARS-CoV-2 spike protein to detect the protein variants. Moreover, we generated its single-chain variable antibody fragment (sc5G2). The sc5G2 expressed in mammalian and bacterial cells detected the spike protein of the original SARS-CoV-2 and variant strains. The resulting sc5G2 will be a useful tool to detect the original SARS-CoV-2 and variant strains.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)不断出现新的变异株,导致疫情持续时间延长。这些突变株的出现使得现有的抗体难以检测到病毒;因此,有必要开发能够针对变异株和原始株的新型抗体。在这项研究中,我们针对 SARS-CoV-2 刺突蛋白的高度保守区域生成了一种高亲和力的单克隆抗体(5G2),以检测该蛋白的变异体。此外,我们还生成了它的单链可变抗体片段(sc5G2)。在哺乳动物和细菌细胞中表达的 sc5G2 可检测到原始 SARS-CoV-2 和变异株的刺突蛋白。所得的 sc5G2 将成为检测原始 SARS-CoV-2 和变异株的有用工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7233/11193732/1d3fdacd7ab1/41598_2024_64103_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验